Life Science Angels
Life Science Angels offers angel capital to early-stage biotech and medical device companies as a California-based company.
Business Model:
Revenue: $5M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Life Science Angels Information
Geographic Data
Address: Life Science Angels Inc 1230 Bordeaux Drive
City: Sunnyvale
State: CA
Zip: 94089
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
5,367,364Website Global Rank
1,719Website Monthly Traffic
Twitter Followers
Description
Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.
Contact Phone:
+14085411152
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2021 | Saccharo | Venture Round | - |
| 3/2008 | Breathe Technologies | Series B | 15M |
| 1/2021 | Watershed Therapeutics | Seed Round | - |
| 11/2009 | Velomedix | Series A | 0 |
| 2/2006 | Verdezyne | Series B | 1.6M |
| 1/2017 | InvVax | Venture Round | - |
| 3/2007 | VasoNova | Series A | 1.3M |
| 1/2020 | iDENTICAL | Seed Round | - |
| 1/2019 | TeVido BioDevices | Venture Round | 1.2M |
| 1/2019 | Purissima | Seed Round | - |
| 9/2019 | VALFIX Medical | Venture Round | 1.1M |
| 12/2019 | S2 Genomics | Seed Round | - |
| 9/2014 | Zephyrus Biosciences | Seed Round | 1.5M |
| 3/2017 | Nanotech Biomachines | Seed Round | - |
| 7/2014 | Nanotech Biomachines | Venture Round | - |
| 1/2020 | Stimwave Technologies | Venture Round | - |
| 1/2020 | BioTrace Medical | Venture Round | - |
| 1/2020 | Eumentis Therapeutics | Seed Round | - |
| 10/2005 | NSpine | Series A | 415k |
| 3/2008 | Satoris | Series B | 5.2M |
| 3/2020 | Noctrix Health | Seed Round | - |
| 1/2020 | Noctrix Health | Seed Round | - |
| 1/2018 | Ark.one Health | Venture Round | - |
| 1/2019 | TransformativeMed | Venture Round | - |
| 1/2020 | Sandstone Diagnostics | Venture Round | - |
| 1/2020 | Inhalon Biopharma | Seed Round | - |
| 3/2019 | Chameleon Biosciences | Seed Round | 3M |
| 7/2007 | Verdezyne | Series C | 7M |
| 6/2005 | Pegasus Biologics | Series B | 10M |
| 1/2018 | TheraDep | Venture Round | - |
| 6/2014 | Trak | Angel Round | 1.8M |
| 1/2015 | AskVet | Seed Round | - |
| 1/2016 | AskVet | Venture Round | - |
| 11/2007 | Vaxart | Series A | 0 |
| 6/2019 | Embolx | Seed Round | - |
| 1/2020 | S2 Genomics | Venture Round | - |
| 4/2021 | Strategikon Pharma | Series A | - |
| 1/2011 | OncoHealth | Angel Round | 1.3M |
| 1/2018 | Seal Rock Therapeutics | Seed Round | - |
| 1/2017 | Seal Rock Therapeutics | Seed Round | - |
| 6/2013 | NuMedii | Series A | 3.5M |
| 5/2013 | Nanostim | Venture Round | 9.5M |
| 1/2017 | Embolx | Venture Round | - |
| 1/2016 | Embolx | Venture Round | - |
| 12/2020 | Strategikon Pharma | Seed Round | - |
| 5/2021 | Astrocyte Pharmaceuticals | Series A | 0 |
| 6/2018 | Mission Bio | Venture Round | - |
| 1/2018 | InvVax | Venture Round | - |
| 3/2022 | InnoSIGN | Series A | 8.1M |
| 6/2012 | Gemmus Pharma | Series A | 1.8M |
| 1/2015 | Retrotope | Series B | 0 |
| 3/2021 | VisiCELL Medical | Venture Round | - |
| 5/2019 | Chimera Bioengineering | Venture Round | 23.2M |
| 9/2021 | Avisi Technologies | Seed Round | 0 |
| 11/2007 | Allylix | Venture Round | 3.4M |
| 1/2019 | S2 Genomics | Venture Round | - |
| 5/2014 | Gemmus Pharma | Series B | 3.3M |
| 9/2018 | Virion Therapeutics | Series A | 0 |
| 8/2013 | Physcient | Series A | 1.9M |
| 1/2021 | Allyx Therapeutics | Venture Round | - |
| 1/2019 | First Light Diagnostics | Series A | 0 |
| 6/2015 | InvVax | Venture Round | - |
| 8/2015 | Ask.Vet | Seed Round | 0 |
| 7/2022 | Avisi Technologies | Seed Round | 4.1M |
| 4/2010 | Allylix | Series C | 3M |
| 6/2005 | Pegasus Biologics | Series B | 10M |
| 3/2020 | Anubis Bio | Seed Round | 1M |
| 11/2009 | Verdezyne | Venture Round | 0 |
| 1/2010 | Vaxart | Series B | 0 |
| 1/2021 | Celldom, Inc | Venture Round | - |
| 5/2011 | OncoHealth | Series A | 1.6M |
| 5/2011 | MoMelan Technologies | Series A | - |
| 8/2006 | Zogenix | Series A | 60M |
| 8/2015 | Thrive Bioscience | Seed Round | 4M |
| 9/2011 | Niveus Medical | Series A | 2M |
| 10/2007 | Fluxion Biosciences | Series B | 7M |
| 8/2013 | Carmenta Bioscience | Seed Round | 2M |
| 10/2017 | Mission Bio | Series A | 10M |
| 4/2013 | nVision Medical | Series A | 0 |
| 4/2010 | Altheos | Series A | 20M |
| 3/2022 | InnoSIGN | Series A | 0 |
| 9/2021 | Avisi Technologies | Seed Round | 0 |
| 5/2021 | Astrocyte Pharmaceuticals | Series A | 0 |
| 4/2021 | Strategikon Pharma | Series A | - |
| 3/2021 | VisiCELL Medical | Venture Round | - |
| 1/2021 | Saccharo | Venture Round | - |
| 1/2021 | Watershed Therapeutics | Seed Round | - |
| 1/2021 | Celldom, Inc | Venture Round | - |
| 1/2021 | Allyx Therapeutics | Venture Round | - |
| 12/2020 | Strategikon Pharma | Seed Round | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
